Wendy C. Burns

4.7k total citations
32 papers, 3.9k citations indexed

About

Wendy C. Burns is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wendy C. Burns has authored 32 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Nephrology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wendy C. Burns's work include Chronic Kidney Disease and Diabetes (10 papers), Connective Tissue Growth Factor Research (9 papers) and Renin-Angiotensin System Studies (9 papers). Wendy C. Burns is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Connective Tissue Growth Factor Research (9 papers) and Renin-Angiotensin System Studies (9 papers). Wendy C. Burns collaborates with scholars based in Australia, United States and Japan. Wendy C. Burns's co-authors include Merlin C. Thomas, Mark E. Cooper, Josephine M. Forbes, Louise M. Burrell, Riccardo Candido, Stephen M. Twigg, Christos Tikellis, Vicki Thallas, Phillip Kantharidis and Karin Jandeleit‐Dahm and has published in prestigious journals such as Circulation, Circulation Research and Diabetes.

In The Last Decade

Wendy C. Burns

32 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy C. Burns Australia 28 1.3k 1.1k 1.1k 1.0k 931 32 3.9k
Zemin Cao Australia 34 995 0.7× 1.4k 1.2× 1.1k 1.0× 473 0.5× 942 1.0× 53 3.4k
Toshiro Sugimoto Japan 41 2.1k 1.6× 607 0.5× 907 0.8× 587 0.6× 1.5k 1.6× 100 5.3k
Alison J. Cox Australia 35 1.2k 0.9× 1.1k 1.0× 961 0.9× 310 0.3× 882 0.9× 71 3.6k
Riccardo Candido Italy 28 1.1k 0.8× 1.1k 1.0× 1.3k 1.2× 578 0.6× 366 0.4× 120 3.5k
Günter Wolf Germany 34 1.6k 1.2× 1.1k 1.0× 722 0.7× 315 0.3× 1.5k 1.6× 70 4.5k
Radko Komers United States 33 1.2k 0.9× 786 0.7× 666 0.6× 299 0.3× 1.2k 1.3× 102 3.6k
Motohide Isono Japan 26 1.6k 1.2× 454 0.4× 589 0.5× 515 0.5× 1.5k 1.6× 43 3.6k
Friedrich Thaiss Germany 35 1.2k 0.9× 813 0.7× 554 0.5× 329 0.3× 1.3k 1.4× 116 4.9k
Kei Fukami Japan 35 1.0k 0.8× 547 0.5× 1.3k 1.2× 2.0k 1.9× 1.0k 1.1× 135 4.5k
Christos Tikellis Australia 25 1.1k 0.8× 1.3k 1.2× 1.2k 1.1× 502 0.5× 318 0.3× 30 3.7k

Countries citing papers authored by Wendy C. Burns

Since Specialization
Citations

This map shows the geographic impact of Wendy C. Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy C. Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy C. Burns more than expected).

Fields of papers citing papers by Wendy C. Burns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy C. Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy C. Burns. The network helps show where Wendy C. Burns may publish in the future.

Co-authorship network of co-authors of Wendy C. Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy C. Burns. A scholar is included among the top collaborators of Wendy C. Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy C. Burns. Wendy C. Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernardi, Stella, Wendy C. Burns, Barbara Toffoli, et al.. (2012). Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1–7). Clinical Science. 123(1). 29–37. 27 indexed citations
2.
Tikellis, Chris, Stella Bernardi, & Wendy C. Burns. (2010). Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease. Current Opinion in Nephrology & Hypertension. 20(1). 62–68. 126 indexed citations
3.
Wang, Bo, Michal Herman‐Edelstein, Philip Koh, et al.. (2010). E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β. Diabetes. 59(7). 1794–1802. 221 indexed citations
4.
Burns, Wendy C. & Merlin C. Thomas. (2010). The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Reviews in Molecular Medicine. 12. e17–e17. 60 indexed citations
5.
Burns, Wendy C. & Merlin C. Thomas. (2010). Angiotensin II and Its Role in Tubular Epithelial to Mesenchymal Transition Associated with Chronic Kidney Disease. Cells Tissues Organs. 193(1-2). 74–84. 34 indexed citations
6.
Burns, Wendy C., Elena Velkoska, Rachael Dean, Louise M. Burrell, & Merlin C. Thomas. (2010). Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1–7/MAS-1-dependent pathways. American Journal of Physiology-Renal Physiology. 299(3). F585–F593. 61 indexed citations
7.
Tikellis, Chris, Philip Koh, Wendy C. Burns, & Phillip Kantharidis. (2008). Quantitative Gene Expression Analysis in Kidney Tissues. Methods in molecular biology. 466. 83–107. 1 indexed citations
8.
Tikellis, Chris, M. E. Cooper, C. I. Johnston, et al.. (2006). Developmental expression of ACE2 in the SHR kidney: A role in hypertension?. Kidney International. 70(1). 34–41. 75 indexed citations
9.
Burns, Wendy C., Stephen M. Twigg, Josephine M. Forbes, et al.. (2006). Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition. Journal of the American Society of Nephrology. 17(9). 2484–2494. 222 indexed citations
10.
Tikellis, Chris, C. I. Johnston, Josephine M. Forbes, et al.. (2004). Identification of angiotensin converting enzyme 2 in the rodent retina. Current Eye Research. 29(6). 419–427. 66 indexed citations
11.
Thomas, Merlin C., Christos Tikellis, Phillip Kantharidis, et al.. (2004). The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes. Journal of Pharmacology and Experimental Therapeutics. 311(2). 456–466. 40 indexed citations
12.
Davis, Belinda J., Josephine M. Forbes, Merlin C. Thomas, et al.. (2004). Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia. 47(1). 89–97. 53 indexed citations
13.
Lassila, Markus, Terri J. Allen, Vicki Thallas, et al.. (2004). Accelerated Nephropathy in Diabetic Apolipoprotein E-Knockout Mouse. Journal of the American Society of Nephrology. 15(8). 2125–2138. 116 indexed citations
14.
Candido, Riccardo, Josephine M. Forbes, Merlin C. Thomas, et al.. (2003). A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes. Circulation Research. 92(7). 785–792. 365 indexed citations
15.
Thomas, Merlin C., Chris Tikellis, Wendy C. Burns, et al.. (2003). Reduced tubular cation transport in diabetes: Prevented by ACE inhibition. Kidney International. 63(6). 2152–2161. 47 indexed citations
16.
Davis, Belinda J., C. I. Johnston, Louise M. Burrell, et al.. (2003). Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy. Diabetologia. 46(7). 961–971. 55 indexed citations
17.
Twigg, Stephen M., Zemin Cao, Sue McLennan, et al.. (2002). Renal Connective Tissue Growth Factor Induction in Experimental Diabetes Is Prevented by Aminoguanidine. Endocrinology. 143(12). 4907–4915. 121 indexed citations
18.
Forbes, Josephine M., Fabrice Bonnet, Leileata M. Russo, et al.. (2002). Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. Journal of Hypertension. 20(5). 985–992. 77 indexed citations
19.
Cao, Zemin, Fabrice Bonnet, Riccardo Candido, et al.. (2002). Angiotensin Type 2 Receptor Antagonism Confers Renal Protection in a Rat Model of Progressive Renal Injury. Journal of the American Society of Nephrology. 13(7). 1773–1787. 102 indexed citations
20.
Ng, Daniel, Charles L. Hardy, Wendy C. Burns, et al.. (2002). Prevention of Diabetes-Induced Albuminuria in Transgenic Rats Overexpressing Human Aldose Reductase. Endocrine. 18(1). 47–56. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026